# Repinotan in Patients With Acute Ischemic Stroke

> **NCT00044915** · PHASE2 · COMPLETED · sponsor: **Bayer** · enrollment: 782 (actual)

## Conditions studied

- Stroke
- Acute Ischemic Stroke

## Interventions

- **DRUG:** Repinotan HCl (BAYX3702)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00044915
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-12
- **Primary completion:** —
- **Final completion:** 2004-09
- **Target enrollment:** 782 (ACTUAL)
- **Last updated:** 2009-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00044915

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00044915, "Repinotan in Patients With Acute Ischemic Stroke". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00044915. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*